Mushrooms are Proving to be Magic for Your Immunity

The magic mushroom story has only just begun.

All thanks to evidence it can help treat a range of psychological issues, including PTSD, addition, eating disorders, depression, and even anxiety. There are even claims mushrooms can even “increase immune resistance to viral and bacterial infection, and also increase our defenses against cancer,” says Dr. Andrew Weil, as quoted by Refinery29.

Researchers form Griffith University, says The New Daily, have said it’s well documented that mushrooms have the “ability to activate cell immunity in humans. They do this through their possession of beta-glucans, which humans don’t have. So, when human cells come into contact with this foreign body, the immune system starts to fire up and respond.”

Reportedly, the mushrooms helped to boost the body’s immune system.

As excitement builds for the use of mushrooms , it’s opening a range of opportunity for companies that have already established launching cannabis products including The Yield Growth Corp. (CSE:BOSS)(OTC:BOSQF), Tilray Inc. (NASDAQ:TLRY), Green Growth Brands Inc. (CSE:GGB)(OTC:GGBXF), GW Pharmaceuticals  (NASDAQ:GWPH), and Cronos Group Inc. (NASDAQ:CRON).

The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWSThe Yield Growth Corp.  announced that the company has completed product development for Ayurvedic mushroom coffees and Ayurvedic mushroom botanical shots for smoothies. “These formulations provide powerful brain and immune-boosting benefits thanks to their powerful antioxidant and nutrient-rich formulas,” said Penny White, CEO of The Yield Growth Corp. “Along with their powerful health profile, these products are made with fair-trade, organic ingredients.”

The Ayurvedic coffees and botanical shots are planned for launch in early summer of 2020 and contain immune-boosting medicinal mushrooms: reishi, chaga, lion's mane and turkey tail. “Immune-boosting foods and supplements are in high demand throughout the cold and flu season and are particularly important for anyone who is especially susceptible to illness, including older individuals or those with chronic conditions may be more vulnerable. The recent Coronavirus outbreak has also sparked increased interest in immune-boosting foods and supplements.”

Chaga mushrooms have been used for centuries in Siberia and Asia as medicine to reduce inflammation, boost immunity and improve overall health. Chaga also has the ability to lower high blood sugar and combat abnormal and mutagenic cell growth. Turkey Tail also contains a community of powerful antioxidants and other compounds that may help boost your immune system and may even fight certain cancers. Some scientific studies have also shown that Turkey Tail may also improve gut bacteria balance.

Reishi is one of the most popular medicinal mushrooms and is known to be used to assist in weight loss, boost immunity and fight certain cancer cells. What makes it unique though are its calming properties thanks to a compound called triterpene that it contains. This can help to promote healing, sharpen focus, alleviate anxiety, ease depression, and encourage better sleep.

Lion’s Mane is also packed with antioxidants and also strengthens the immune system, but it also has other unique benefits that foster mental clarity and brain health. For example, it aids in the production of the bioprotein nerve growth factor (NFG) and myelin, which acts as “insulation” around nerve fibers and helps to fight the onset of neurological diseases such as Alzheimer’s and multiple sclerosis.

"For centuries humans around the globe have used herbs and plants to cure or prevent illness. Plants are the life force energy for our food, oxygen, and medicine,” said Bhavna Solecki, director of product development for The Yield Growth Corp. “We are working to bring these ancient traditions and plant-based remedies mainstream.”

The Ayurvedic shots contain herbs such as holy basil and moringa. Holy basil, known as the “Queen of Herbs” helps to build natural immunity, detoxify blood and promotes cellular regeneration. It also acts as a strong antiseptic against many kinds of disease-causing organisms, including bacteria, fungi, and parasites. Moringa is referred to as the “Tree of Life” in India. Moringa leaf is a rich source of nutrients and antioxidants and has super immune-boosting powers. It supports the liver as an antioxidant, helps to relieve allergies and stomach disorders and also is known to act as an antidepressant.

Other related developments from around the markets include:

Tilray Inc. (NASDAQ:TLRY) will report results for the fourth quarter and full fiscal year ended December 31, 2019 on Monday, March 2, 2020 after market close. The Company will host a conference call to discuss these results at 5:00 p.m. ET. Investors interested in participating in the live call can dial 877-489-6528 from the U.S. and 629-228-0736 internationally. A telephone replay will be available approximately two hours after the call concludes through Monday, March 16, 2020, by dialing 855-859-2056 from the U.S., or 404-537-3406 from international locations.

Green Growth Brands Inc. (CSE:GGB)(OTC:GGBXF) reported its results for the period ended December 28, 2019. Revenues for the period totaled $21.1M. “The results this quarter are a reflection of our ability to create products and experiences that consumers want,” said Peter Horvath, CEO of Green Growth Brands. “We are pleased with the consumer demand signals we saw in the CBD segment during the quarter, and we remain confident in its future potential. However, overhead costs, near-term obligations and constraints on liquidity have posed significant challenges that have hindered us from growing the CBD business in the timeframes we anticipated to its full-potential. “The initiatives we announced today to sell the CBD segment, restructure debt and raise equity financing improves the financial infrastructure we need to scale our MSO segment. We believe focusing our expertise on the MSO segment will yield the highest long-term value for our shareholders and customers.”

GW Pharmaceuticals (NASDAQ:GWPH) announced financial results for the fourth quarter and full-year ended December 31, 2019. “2019 was an exceptional and transformative year for GW, led by the successful launch of Epidiolex in the US and approval in Europe. The positive impact this medicine has had on thousands of patients and their families provides a compelling foundation for continued growth in 2020,” said Justin Gover, GW’s Chief Executive Officer. “We also expect 2020 to be an important year for our growing and developing product pipeline beyond Epidiolex as we build on our world leadership in cannabinoid science. We are focused on advancing nabiximols in the US in several indications and clinical programs with other potential products whilst continuing to bring Epidiolex to more patients in the US and Europe.”

Cronos Group Inc. (NASDAQ:CRON) announced that it will delay its 2019 fourth quarter and full-year earnings release and conference call, previously scheduled for Thursday, February 27, 2020. The Company has had a delay in the completion of its financial statements and will make a further announcement in a subsequent press release to schedule the date and time of the earnings conference call.

Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of and The Yield Growth Corp., Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer.

Contact Information:
[email protected]